View Author

Albertsson, P.A.

(Per Albertsson)


stent fi ve years patient group event follow-up stent group balloon angioplasty angioplasty stent implantation study trial benestent-i trial implantation benestent-i balloon stenting month difference survival 5 yrs revascularization procedure event-free end points lesion randomized artery death signi cerebrovascular event-free survival disease ptca group buenos aires hospital anginal status result cerebrovascular events palmaz-schatz point target signi ficant differences ptca groups infarction kiemeneij jacc vol angina pectoris angina end point restenosi status anginal incidence target lesion palmazschatz stent implantation 256 patients randomized benestent-i randomized trial american college medication patients randomized baim ds percutaneou netherland 516 patients palmaz-schatz stent implantation accident palmaz-schatz stenting 12 months benestent study group target lesion revascularization ziekenhui belgium kaplan-meier event-free curves serruy mortality ficant stented target site bene fit curve




2 Most Recent Publications

Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. (Article)
Kiemeneij, F. Serruys, P.W.J.C. Colombo, A. Goy, J-J. Disco, C. Morel, M-A.M. Albertsson, P.A. Macaya Miguel, C.M. Rutsch, W.R. Heyndrickx, G.R. Fajadet, J. Legrand, V.M.G. Materne, P.H. Belardi, J.A. Sigwart, U.
2001-05-10
Reduction in Thrombotic Events With Heparin-Coated Palmaz-Schatz Stents in Normal Porcine Coronary Arteries. (Article)
Hardhammar, P.A. Emanuelsson, H.U. Hofma, S.H. Albertsson, P.A. Verdouw, P.D. Boersma, H. Serruys, P.W.J.C. Giessen, W.J. van der Beusekom, H.M.M. van
1996-01-01